BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessAXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple IndicationsBy Nasdaq OMXOct 26, 2016, 1:04 PM UTC
BusinessAXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug Market at Money Show DallasBy Nasdaq OMXOct 19, 2016, 1:02 PM UTC
BusinessAXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug Market at Money Show DallasBy Nasdaq OMXOct 19, 2016, 1:02 PM UTC
BusinessAXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse EpidemicBy Nasdaq OMXMar 31, 2016, 1:00 PM UTC
